Andrew P. Rasdal served as the President and CEO of DexCom, Inc., a company focused on diabetes management. He was at the helm during a critical time and was instrumental in shaping the company's strategic direction. Born on November 30,...

Andrew P. Rasdal served as the President and CEO of DexCom, Inc., a company focused on diabetes management. He was at the helm during a critical time and was instrumental in shaping the company's strategic direction. Born on November 30, 1961, Rasdal has a background in business leadership, particularly in the medical technology field. During his tenure in 2007, his total compensation was reported at approximately $897,112, which included a base salary of $452,308 and a notable absence of bonuses due to unmet revenue targets. This reflects a compensation structure tied closely to performance metrics, emphasizing accountability. In 2007, Rasdal decided to reduce his annual salary to $300,000, showing his commitment to aligning his interests with the company's performance. His leadership was marked by a focus on innovation and driving revenue growth, critical for companies in the healthcare sector. Rasdal's decision to resign from the board of directors right before leaving the CEO role on June 19, 2007, indicates a significant transition for the company as it sought new leadership to guide its growth strategy.